CONTACT US
News and Stories About FDA
Another FDA Treatment Approval Underscores Promise of Precision Medicine
September 22, 2022
The FDA granted approval for a treatment targeting a genetic alteration called RET fusion.
Lynparza Approved for Pancreatic Cancer Patients Identified by Testing
December 30, 2019
Today the U.S. Food and Drug Administration (FDA) approved the targeted therapy Lynparza® (olaparib) for the treatment of patients who […]
READ MORE
FDA Hosts Patient Advocacy Leaders
October 10, 2019
Patient advocacy leaders, including Pancreatic Cancer Action Network’s (PanCAN) chief medical officer Victoria Manax, MD, gave opening remarks at the […]
READ MORE
